Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?

Studies have revealed a robust and independent correlation between chronic kidney disease (CKD) and cardiovascular (CV) events, including death, heart failure, and myocardial infarction. Recent clinical trials extend this range of adverse CV events, including malignant ventricular arrhythmias and su...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Márcio Galindo Kiuchi, Jan K. Ho, Janis Marc Nolde, Leslie Marisol Lugo Gavidia, Revathy Carnagarin, Vance B. Matthews, Markus P. Schlaich
Format:	Artikel
Sprache:	English
Veröffentlicht:	Frontiers Media S.A. 2020-01-01
Schriftenreihe:	Frontiers in Physiology
Schlagworte:	chronic kidney disease sympathetic nervous system hypertension left ventricular hypertrophy sudden cardiac death ventricular remodeling
Online Zugang:	https://www.frontiersin.org/article/10.3389/fphys.2019.01546/full

Ähnliche Einträge

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
von: Janis M. Nolde, et al.
Veröffentlicht: (2021-08-01)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
von: Revathy Carnagarin, et al.
Veröffentlicht: (2019-01-01)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
von: Márcio Kiuchi, et al.
Veröffentlicht: (2019-12-01)

The effect of bilateral cardiac sympathetic denervation for refractory ventricular tachycardia in ischemic cardiomyopathy
von: Yuko Miki, et al.
Veröffentlicht: (2020-06-01)

Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
von: Márcio G. Kiuchi, et al.
Veröffentlicht: (2016-03-01)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
von: Lakshini Y. Herat, et al.
Veröffentlicht: (2018-01-01)

Microvascular changes at different stages of chronic kidney disease
von: Dennis Kannenkeril, et al.
Veröffentlicht: (2021-02-01)

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
von: Veronica Dusi, et al.
Veröffentlicht: (2021-01-01)

Device-based approaches for renal nerve ablation for hypertension and beyond
von: Alicia Ann Thorp, et al.
Veröffentlicht: (2015-07-01)

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
von: Leslie Marisol Lugo‐Gavidia, et al.
Veröffentlicht: (2022-06-01)

Sudden Cardiac Death and Idiopathic Ventricular Arrhythmias
von: Vries Lennart de, et al.
Veröffentlicht: (2015-12-01)

Transgenic models of cardiac arrhythmias and sudden death
von: Carol Ann eRemme
Veröffentlicht: (2013-03-01)

The Schlager mouse as a model of altered retinal phenotype
von: Lakshini Y Herat, et al.
Veröffentlicht: (2020-01-01)

Evidence of Ventricular Arrhythmogenicity and Cardiac Sympathetic Hyperinnervation in Early Cirrhotic Cardiomyopathy
von: Shin-Huei Liu, et al.
Veröffentlicht: (2021-12-01)

Efficacy and safety of cardiac sympathetic denervation for refractory ventricular arrhythmias: Experience of a Colombian hospital
von: Nicolas Arredondo-Mora, et al.
Veröffentlicht: (2024-03-01)

Cardiac Sympathetic Denervation in Channelopathies
von: Veronica Dusi, et al.
Veröffentlicht: (2019-03-01)

Sympathetic Activation and Arrhythmogenesis after Myocardial Infarction: Where Do We Stand?
von: Konstantinos C. Zekios, et al.
Veröffentlicht: (2021-05-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
von: P.C. Brum, et al.
Veröffentlicht: (2011-09-01)

Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function
von: P.C. Brum, et al.
Veröffentlicht: (2011-09-01)

Effects of Renal Denervation on Sympathetic Activation, Blood Pressure and Glucose Metabolism in Patients with Resistant Hypertension
von: Markus Peter Schlaich, et al.
Veröffentlicht: (2012-02-01)

Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application?
von: Philipp Sasse, et al.
Veröffentlicht: (2019-06-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
von: D. S. Lebedev, et al.
Veröffentlicht: (2021-08-01)

Case Report: The unrelenting journey—successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation
von: Hei-To Leung, et al.
Veröffentlicht: (2024-12-01)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
von: Janis M. Nolde, et al.
Veröffentlicht: (2021-01-01)

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmia in Continuous-Flow Left Ventricular Assist Device
von: Peter P. Vlismas, MD, et al.
Veröffentlicht: (2021-03-01)

Comments on 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
von: Ali Deniz, et al.
Veröffentlicht: (2016-02-01)

Editorial: The role of sex in cardiac arrhythmias and sudden cardiac death
von: Matias E. Pollevick, et al.
Veröffentlicht: (2023-03-01)

Renal sympathetic denervation assisted treatment of electrical storm due to polymorphic ventricular tachycardia in a patient with cathecolaminergic polymorphic ventricular tachycardia
von: Tolga Aksu, et al.
Veröffentlicht: (2017-07-01)

Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
von: Alicia A. Thorp, et al.
Veröffentlicht: (2015-01-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
von: Masayoshi Mori, et al.
Veröffentlicht: (2024-08-01)

Acute hemodynamics of cardiac sympathetic denervation
von: Kunal Sinkar, et al.
Veröffentlicht: (2020-11-01)

Central sympathetic activation and arrhythmogenesis during acute myocardial infarction: modulating effects of endothelin-B receptors
von: Theofilos M Kolettis, et al.
Veröffentlicht: (2015-02-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
von: Brian P. Betensky, et al.
Veröffentlicht: (2014-01-01)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
von: Revathy Carnagarin, et al.
Veröffentlicht: (2021-07-01)

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58%
von: Toshihiko Goto, et al.
Veröffentlicht: (2022-06-01)

Alcohol Ablation for Cardiac Arrhythmias: Is it Time to Drown the Arrhythmias?
von: Anandaraja Subramanian, MD, DM, FCE
Veröffentlicht: (2012-07-01)

QUANTIFICATION OF ELECTROCARDIOGRAM RHYTHMICITY TO DETECT LIFE THREATENING CARDIAC ARRHYTHMIAS USING SPECTRAL ENTROPY
von: CHANDRAKAR KAMATH
Veröffentlicht: (2013-10-01)

RISK STRATIFICATION OF SUDDEN CARDIAC DEATH IN EARLY REPOLARIZATION SYNDROME
von: Shpak N. V., et al.
Veröffentlicht: (2019-11-01)

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
von: Jia Liao, et al.
Veröffentlicht: (2024-02-01)

Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome
von: Elisabeth Annie Lambert, et al.
Veröffentlicht: (2011-08-01)